Binding of FAD to 6-hydroxy-D-nicotine oxidase apoenzyme prevents degradation of the holoenzyme.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 1138339)

Published in Biochem J on February 15, 1989

Authors

R Brandsch1, V Bichler, B Krauss

Author Affiliations

1: Biochemisches Institut, Universität Freiburg, Federal Republic of Germany.

Articles cited by this

Evidence for two functional gal promoters in intact Escherichia coli cells. J Biol Chem (1981) 17.42

Escherichia coli recA gene product inactivates phage lambda repressor. Proc Natl Acad Sci U S A (1978) 5.42

The mechanism of protein secretion across membranes. Nature (1980) 4.72

Heat shock regulatory gene htpR influences rates of protein degradation and expression of the lon gene in Escherichia coli. Proc Natl Acad Sci U S A (1984) 3.33

A multiple-component, ATP-dependent protease from Escherichia coli. J Biol Chem (1987) 2.15

Escherichia coli contains a soluble ATP-dependent protease (Ti) distinct from protease La. Proc Natl Acad Sci U S A (1987) 1.87

Purification and properties of tryptophan-synthase-inactivating enzymes from yeast. Eur J Biochem (1972) 1.77

Proteases in Escherichia coli. Methods Enzymol (1981) 1.72

Purification of a protease from Escherichia coli with specificity for oxidized glutamine synthetase. J Biol Chem (1987) 1.68

6-Hydroxy-D-nicotine oxidase of Arthrobacter oxidans. Gene structure of the flavoenzyme and its relationship to 6-hydroxy-L-nicotine oxidase. Eur J Biochem (1987) 1.18

A new enzyme that specifically inactivates apo-protein of pyridoxal enzymes. Biochem Biophys Res Commun (1971) 1.17

Plasmid pAO1 of Arthrobacter oxidans encodes 6-hydroxy-D-nicotine oxidase: cloning and expression of the gene in Escherichia coli. Mol Gen Genet (1986) 1.09

Proteolysis in eukaryotic cells. Proteinase yscE, a new yeast peptidase. J Biol Chem (1984) 1.04

Covalent flavinylation of 6-hydroxy-D-nicotine oxidase involves an energy-requiring process. FEBS Lett (1987) 0.98

Covalently bound flavin in D-6-hydroxynicotine oxidase from Arthrobacter oxidans. Identification of the 8 -(N-3-histidyl)-riboflavin-linkage between FAD and apoenzyme. Eur J Biochem (1972) 0.98

A novel proteolytic activity apparently initiating degradation of beta-galactosidase nonsense fragments in in vitro extracts of Escherichia coli. J Biol Chem (1983) 0.98

Purification and some properties of tryptophan synthase inactivase II from yeast. Eur J Biochem (1974) 0.90

A new enzyme that specifically inactivates apo-protein of NAD-dependent dehydrogenases. Biochem Biophys Res Commun (1971) 0.90

Covalent flavinylation of 6-hydroxy-D-nicotine oxidase analyzed by partial deletions of the gene. Eur J Biochem (1987) 0.82

Articles by these authors

The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med (1996) 1.87

Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. J Cell Sci (1994) 1.70

Adverse events of procedural sedation and analgesia in a pediatric emergency department. Ann Emerg Med (1999) 1.39

The semantics of ketamine. Ann Emerg Med (2000) 1.24

Electromagnetic versus fluoroscopic mapping of the inferior isthmus for ablation of typical atrial flutter: A prospective randomized study. Circulation (2000) 1.14

Comparison of electrical velocimetry and thermodilution techniques for the measurement of cardiac output. Acta Anaesthesiol Scand (2007) 1.09

Hypoxia induces c-fos transcription via a mitogen-activated protein kinase-dependent pathway. J Biol Chem (1997) 1.05

Automatic bone and plaque removal using dual energy CT for head and neck angiography: feasibility and initial performance evaluation. Eur J Radiol (2009) 1.02

Dual-energy CT in the evaluation of intracerebral hemorrhage of unknown origin: differentiation between tumor bleeding and pure hemorrhage. AJNR Am J Neuroradiol (2012) 1.00

Covalent flavinylation of 6-hydroxy-D-nicotine oxidase involves an energy-requiring process. FEBS Lett (1987) 0.98

Autoflavinylation of apo6-hydroxy-D-nicotine oxidase. J Biol Chem (1991) 0.98

Gene structures and properties of enzymes of the plasmid-encoded nicotine catabolism of Arthrobacter nicotinovorans. J Mol Biol (1998) 0.98

In vivo and in vitro expression of the 6-hydroxy-D-nicotine oxidase gene of Arthrobacter oxidans, cloned into Escherichia coli, as an enzymatically active, covalently flavinylated polypeptide. FEBS Lett (1985) 0.95

Microstream capnograpy technology: a new approach to an old problem. J Clin Monit Comput (1999) 0.94

Site-directed mutagenesis of the FAD-binding histidine of 6-hydroxy-D-nicotine oxidase. Consequences on flavinylation and enzyme activity. FEBS Lett (1989) 0.93

Functional analysis of the 5' regulatory region and the UUG translation initiation codon of the Arthrobacter oxidans 6-hydroxy-D-nicotine oxidase gene. Mol Gen Genet (1990) 0.92

Continuous-flow nitrous oxide: searching for the ideal procedural anxiolytic for toddlers. Ann Emerg Med (2001) 0.91

Relationships of clinical protocols and reconstruction kernels with image quality and radiation dose in a 128-slice CT scanner: study with an anthropomorphic and water phantom. Eur J Radiol (2011) 0.88

Covalent cofactor binding to flavoenzymes requires specific effectors. Eur J Biochem (1989) 0.88

Suppression of heart rate variability after supramaximal exertion. Clin Physiol Funct Imaging (2007) 0.86

Antibody production against an agonist analogue of luteinizing hormone-releasing hormone: evaluation of immunochemical and physiological consequences. Acta Endocrinol (Copenh) (1983) 0.84

High-pitch dual-source CT angiography of supra-aortic arteries: assessment of image quality and radiation dose. Neuroradiology (2012) 0.84

Covalent flavinylation of 6-hydroxy-D-nicotine oxidase analyzed by partial deletions of the gene. Eur J Biochem (1987) 0.82

Cysteine to serine replacements in 6-hydroxy-D-nicotine oxidase. Consequences for enzyme activity, cofactor incorporation, and formation of high molecular weight protein complexes with molecular chaperones (GroEL). J Biol Chem (1993) 0.82

Lysine can replace arginine 67 in the mediation of covalent attachment of FAD to histidine 71 of 6-hydroxy-D-nicotine oxidase. J Biol Chem (1990) 0.81

Performance differences between addicts and non-addicts. Psychopharmacology (Berl) (1977) 0.81

Phosphoenolpyruvate-dependent flavinylation of 6-hydroxy-D-nicotine oxidase. Eur J Biochem (1988) 0.80

Studies in vitro on the flavinylation of 6-hydroxy-D-nicotine oxidase. Eur J Biochem (1986) 0.80

Pharmacokinetics and endocrine effects of the LHR analogue buserelin after subcutaneous implantation of a slow release preparation in prostatic cancer patients. Urol Res (1989) 0.80

The relation between pharmacokinetics and endocrine effects of buserelin implants in patients with mastalgia. Clin Endocrinol (Oxf) (1991) 0.79

Inhibitory control of the pituitary LH secretion by LH-RH in male rats. Horm Res (1979) 0.79

[Lung complications in AIDS]. Radiologe (1986) 0.79

Combined stentless mitral valve implantation and radiofrequency ablation. Ann Thorac Surg (2000) 0.79

GroE dependence of refolding and holoenzyme formation of 6-hydroxy-D-nicotine oxidase. J Biol Chem (1992) 0.78

Enzyme kinetic studies and inhibition by oligopeptides of LH-RH degradation in rat hypothalamus and pituitary. Neuroendocrinology (1979) 0.77

Accuracy of capnography with a 30 foot nasal cannula for monitoring respiratory rate and end-tidal CO2 in children. J Clin Monit Comput (2000) 0.77

Ketamine is a safe, effective, and appropriate technique for emergency department paediatric procedural sedation. Emerg Med J (2004) 0.77

Dual-energy computed tomography after endovascular aortic aneurysm repair: the role of hard plaque imaging for endoleak detection. Eur Radiol (2014) 0.76

Sensing lead insulation defect resulting in a damage of the ICD pulse generator case. Pacing Clin Electrophysiol (1998) 0.76

Riboflavin-dependent expression of flavoenzymes of the nicotine regulon of Arthrobacter oxidans. Biochem J (1990) 0.75

[Comparison of mammography and automated sonography in 700 patients]. Rofo (1983) 0.75

[Liver diseases in diabetes mellitus]. Z Gesamte Inn Med (1975) 0.75

Q2 dependence of nuclear transparency for exclusive rho0 production. Phys Rev Lett (2003) 0.75

Studies on enzyme stability of luteinizing hormone releasing hormone analogues [proceedings]. J Endocrinol (1979) 0.75

[Dual-source CT: in vitro characterization of gallstones using dual energy analysis]. Rofo (2009) 0.75

[Effects of terbuthylazine on photo-autotrophic organisms in the aquatic ecosystem]. Schriftenr Ver Wasser Boden Lufthyg (1992) 0.75

[Nuclear magnetic resonance tomography in destructive changes of the spine]. Z Orthop Ihre Grenzgeb (1990) 0.75

[Osteopetrosis--Albers-Schönberg disease from the viewpoint of MR tomographic findings]. Rofo (1987) 0.75

Evidence for quark-hadron duality in the proton spin asymmetry A1. Phys Rev Lett (2003) 0.75

Single-spin asymmetries in semi-inclusive deep-inelastic scattering on a transversely polarized hydrogen target. Phys Rev Lett (2005) 0.75

[Interpretation and evaluation of somatic diseases in the elderly]. Internist (Berl) (1974) 0.75

[Cardiac dynamics time intervals during physical exertion in patients with acquired and congenital heart defects]. Z Kreislaufforsch (1970) 0.75

Double-hadron leptoproduction in the nuclear medium. Phys Rev Lett (2006) 0.75

[Increase of serum gamma-GT activity in alcoholism and chronic abuse of hypnotics (author's transl)]. Nervenarzt (1978) 0.75

[Observations on transformations of manic phases in long-term therapy with lithium]. Nervenarzt (1971) 0.75

Action of tulobuterol and fenoterol on the mucociliary clearance. Respiration (1987) 0.75

Flavor decomposition of the sea-quark helicity distributions in the nucleon from semiinclusive deep inelastic scattering. Phys Rev Lett (2004) 0.75

Destructive changes of the spine in magnetic resonance imaging. Arch Orthop Trauma Surg (1990) 0.75

Measurement of the tensor structure function b1 of the deuteron. Phys Rev Lett (2005) 0.75

Joint Commission on Accreditation of Healthcare Organizations: friend, not foe. J Am Diet Assoc (2000) 0.75

[Clinical use of gradient echo sequences of longer repetition times]. Rofo (1988) 0.75

[Kidney function and prostatic disease in the aged]. Z Gerontol (1982) 0.75